Skip to main content
Premium Trial:

Request an Annual Quote

Sense Biodetection, Cruinn Diagnostics Ink Distribution Deal for COVID-19 Test in Ireland

NEW YORK – Sense Biodetection announced on Wednesday that it has inked a strategic distribution agreement with Cruinn Diagnostics for Sense's COVID-19 test in Ireland.

Cruinn is one of several planned EU distribution partners for the Veros COVID-19 test, Sense Biodetection said in a statement, including Una Health in the UK. Financial and other terms of the deal were not disclosed. 

The single-use test uses a proprietary enzymatic nucleic acid amplification chemistry that does not require an instrument and returns results in 15 minutes. It received CE marking last week and is intended for use in point-of-care settings. 

The Veros COVID-19 test will be the first instrument-free molecular test for COVID-19 to enter the Irish market, Aidan Wearen, Cruinn's head of marketing and sales, noted in a statement.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.